Low-voltage computed tomographic angiography (CTA) is a highly effective technique to reduce contrast media volume. We sought to examine the suitability of low tube voltage CTA with a reduced contrast media volume protocol using third-generation 192-slice dual-source CT in patients undergoing transcatheter aortic valve implantation (TAVI). CTA was performed to aid TAVI planning for 40 consecutive patients with severe aortic stenosis. For the first 10 patients (120/100 kV group), we used a conventional tube voltage combined CTA protocol (an ECG-gated helical scan; 120 kV, non-gated helical scan; 100 kV). For the subsequent 30 patients (70-kV group), we adopted a low tube voltage CTA protocol. We evaluated vascular attenuation, image noise, contrast-to-noise ratio (CNR), and renal function. The mean contrast media (CM) volume was 77.7 ± 17.7 mL in the 120/100-kV group and 30.9 ± 6.3 mL in the 70-kV group (P < 0.001). In the images of the aortic valve complex, the mean attenuation was not significant difference for both groups. In the images of the aorto-femoral arteries, mean attenuation was > 250 Hounsfield Units and CNR was > 10 in all vascular segments for both groups. There was no significant difference in the change of renal function in the 70-kV group, but renal function in the 120/100-kV group decreased within 1-3 months after CTA. Low tube voltage CTA using third-generation dual-source CT is suitable to assess procedural planning for TAVI. This approach maintains image quality and reduces the required CM volume.
T ranscatheter aortic valve implantation (TAVI) is considered to be an alternative treatment for aortic stenosis (AS) in high-risk patients. 1, 2) Computed tomographic angiography (CTA) plays an important role in TAVI screening; by facilitating the assessment of the aorto-ilio-femoral artery and the dimensions of the aortic annulus, CTA enables the informed selection of the access route and sizing of the prosthetic valve. 3, 4) Renal dysfunction is a common comorbidity in patients undergoing TAVI. 5) High-dose administration of contrast media (CM) when performing CTA increases the risk of contrast-induced nephropathy (CIN). [6] [7] [8] In addition, advanced age and renal and cardiac dysfunction have been considered important CIN risk factors; 9) elderly patients receiving TAVI are at high risk of CIN. Renal dysfunction is one of the predictors for the postoperative prognosis of TAVI 10) ; thus, it is desirable to minimize the dose of CM to reduce the incidence of CIN and prevent decreased renal function.
Low-voltage CTA is a highly effective technique for CM volume reduction. Low-voltage CTA improves the effect of the iodinated contrast agent, since the mass attenuation coefficient of iodine increases as the X-ray energy is reduced. 11, 12) A previous study has reported success using low tube voltage techniques of second-generation dualsource CT (DSCT) system for TAVI planning. 13) But, low tube voltage imaging increased image noise unless tube current output was increased in previous reports. 14, 15) Third-generation DSCT systems provide images with reduced noise, owing to substantially higher tube current output at low tube voltage than conventional DSCT systems. 16) Combining third-generation DSCT with the use of low tube voltage protocols, the CM dose necessary to obtain high-quality images might be further reduced. Also, there was no report comparing low tube voltage and conventional tube voltage using third-generation DSCT in patients for TAVI. Thus, the purpose of this study was to examine the suitability of low tube voltage CTA compared ONODA, ET AL to conventional tube voltage using third-generation 192slice DSCT in combination with reduced contrast media dose protocols for patients undergoing TAVI.
Methods

Patient selection:
Between June 2015 and September 2016, CTA was performed to aid TAVI planning for 40 consecutive patients with severe symptomatic AS. We used a conventional tube voltage combined CTA protocol for the first 10 patients (120/100-kV group). For the 30 subsequent patients (70-kV group), we adopted a low tube voltage CTA protocol. This study was approved by the local ethics committee (approval number: 30-416) and all patients provided informed consent. Acquisition protocol and radiation dose: CTA was performed for all patients using a third-generation 192-slice DSCT scanner (Somatom Force, Siemens Healthcare, Forchheim, Germany), using a tube voltage of 70 or 120/ 100 kV, a gantry rotation time of 0.25 seconds, and a detector collimation of 2 × 192 × 0.6 mm. A conventional tube voltage protocol consisted of two successive CTA scans: a caudo-cranial direction ECG-gated helical scan (120 kV) to evaluate the aortic valve complex, followed by a cranio-caudal direction non-gated helical scan (100 kV) to evaluate the aorto-femoral arteries. In the 70-kV group, we adopted a tube voltage of 70-kV CTA protocol with the same scanning procedure as the 120/100-kV group. For all CTA examinations, automated tube current modulation (CAREDose 4D, Siemens) was enabled. The reference tube currents were 360 mAs as 120 kV for the aortic valve complex, and 240 mAs as 120 kV for the aorto-femoral arteries. For all patients, two reconstructions were rendered. The first was a small field of view (FOV) data set to evaluate the aortic valve complex at the 20% phase of the cardiac cycle and used a medium soft-tissue convolution kernel (Siemens Bv40), a pitch factor of 0.15, a slice thickness of 0.75 mm, and a slice increment of 0.3 mm. The second reconstruction was a large FOV data set to evaluate the aorto-femoral arteries and used a different convolution kernel (Siemens Br44), a pitch factor of 1.55, a slice thickness of 1.0 mm, and a slice increment of 0.7 mm. All scan parameters are provided in Table I . CTA was performed using monomeric, non-ionic, low-osmolar iodinated CM (300 mgI/mL; Iopromide; Bayer Healthcare, Berlin, Germany). Bolus tracking software was used to start the scan automatically after the attenuation in the region of interest (ROI) in the ascending aorta reached 100 Hounsfield Units (HU). The 120/100-kV group received a CM bolus of 1.47 mL/kg, followed by a saline flush of 25 mL over a total injection time of 18 seconds. The 70-kV group received a 6:4 mixture of CM-to-saline bolus (total CM amount 0.65 mL/kg), followed by a saline flush of 25 mL over a total injection time of 18 seconds. For each study group, the effective dose was calculated by multiplying the dose-length product (DLP) value by the conversion factor (k = 0.014 mSv/[mGy.cm]).
Assessment of image quality:
We evaluated image quality using the following objective parameters: CT attenuation, image noise, and contrast-to-noise ratio (CNR). These were measured in circular ROIs at different locations: the ascending aorta, aortic arch, descending thoracic aorta, infrarenal abdominal aorta, and both common femoral arteries. The ascending aorta was evaluated by the cardiac protocol, and the others were evaluated by the aortic protocol. Image noise was defined as the standard deviation (SD) of each vessel's ROI measurement. The CNR was defined as vessel enhancement (HU) minus adjacent muscle tissue enhancement, divided by the SD in adjacent muscle tissue enhancement. Images were analyzed using a ZioStation computer workstation (Ziosoft, Osaka, Japan).
Measurement of aortic valve complex:
After an appropriate plane that exactly contains the three lowest insertion points of the coronary cusps had been created, the annulus area was measured by two observers separately according to the SCCT expert consensus document. 3) Renal function: Estimated glomerular filtration rates (eGFRs; mL/minute/1.73 m 2 ) and serum creatinine (SCr; mg/dL) were measured to evaluate renal function before CTA was performed, and again within 3 days post-CT imaging as the acute phase. CIN was defined as either a 25% increase in SCr from baseline, or a 0.5 mg/dL increase in absolute value, within 72 hours of intravenous contrast administration. 17) The eGFR values 1-3 months after CTA were also measured before TAVI or surgical aortic valve replacement (SAVR) to evaluate medium-term changes in renal function. Preventive therapy to improve renal function, such as intravenous hydration therapy, was LOW TUBE VOLTAGE IN 3RD DSCT BEFORE TAVI All tests were two-sided. A P-value less than 0.05 was considered significant. For the aortic annulus area of both groups, the intraclass correlation coefficient (ICC) was calculated to evaluate the level of interobserver reliability between two observers. ICCs values of > 0.80 were considered excellent.
Results
Patient characteristics: Baseline characteristics are displayed in Table II . Three of the 10 patients in the 120/ 100-kV group and 11 of the 30 patients in the 70-kV group were male. The average age was 83.5 ± 6.0 years in the 120/100-kV group and 83.9 ± 6 years in the 70-kV group. A comparison of characteristics showed that the 120/100-kV group of patients had a higher body mass index (BMI) (23.4 ± 4.8 versus 20.3 ± 3.6 kg/m 2 , P = 0.04). There were no significant differences in other baseline characteristics. For all CTA examinations, TAVI planning measurements were performed successfully, without complications.
Radiation dose and CM volume:
The mean DLP and mean effective radiation dose were higher in the 120/100-kV group than in the 70-kV group (mean DLP: 2405 ± 333 versus 819 ± 122 mGy × cm, P < 0.001; mean effective radiation dose: 33.7 ± 4.7 versus 11.4 ± 1.7 mSv, P < 0.001). The mean CM volume was 77.7 ± 17.7 mL in the 120/100-kV group and 30.9 ± 7.1 mL in the 70-kV group (P < 0.001).
Image quality: Table III shows the results of the objec-tive image quality assessments for each vascular region. All patients were diagnostically sufficient for aortic valve complex and aorto-femoral anatomy. In the images of the aortic valve complex, the mean attenuation at the ascending aorta was not significantly different for the 120/100-kV group compared with the 70-kV group (mean attenuation: 430.7 ± 112.5 versus 412.8 ± 58.7 HU, P = 0.52), whereas better image noise and CNR was observed for 120/100-kV group (image noise: 18.9 ± 5.9 versus 26.2 ± 5.6 HU, P = 0.001; CNR: 31.6 ± 9.2 versus 21.6 ± 6.7, P < 0.001). In the images of the aorto-femoral arteries, the mean attenuation, image noise, and CNR were also significantly better for the 120/100-kV group at each of the other vessel segments (P !0.02). The mean attenuation was > 250 HU and the CNR was > 10 in all vascular segments for both groups. Interobserver reliability regarding the mean aortic annulus area was excellent in both the groups (ICC: 0.999 for 120/100-kV group and 0.978 for 70-kV group). Figure 1 shows representative images from each group. Although the image noise in the 70-kV group was higher, all images were acceptable for TAVI planning and capable of constructing volume rendering. Renal function: Results of eGFR measurements are shown in Table IV and Figure 2 . The mean eGFR within 3 days after CTA was 72.8 ± 27.8 and 55.4 ± 25.8 mL/ minute/1.73 m 2 for the 120/100-and 70-kV groups, respectively (P = 0.07). The differences between eGFR measurements before CTA and within 3 days after CTA were calculated; there was no significant difference between the two experimental groups by this metric (120/ 100 versus 70-kV groups; -2.18 ± 4.2 versus -1.0 ± 8.1 mL/minute/1.73 m 2 , P = 0.66). CIN was observed in 0 of 10 patients in the 120/100-kV group and 1 of 30 patients in the 70-kV group, but there was no significant difference between the groups (P = 0.56). No renal failure occurred that required dialysis or caused kidney-related death. Evaluation of the eGFR between 1 and 3 months after CTA was possible for all subjects except one of the 120/100-kV group. There was no significant difference in measured eGFR 1-3 months after CTA between the 120/ 100-and the 70-kV groups (64.2 ± 25.9 versus 63.6 ± 25.0 mL/minute/1.73 m 2 , P = 0.95). There was no significant difference in the change of renal function for the 70-kV group, but renal function for the 120/100-kV group decreased within 1-3 months after CTA (75.0 ± 28.4 ver-ONODA, ET AL occurred as oozing rupture of the sinus of Valsalva with cardiac tamponade in the 70-kV group. The patient was treated by manual compression with thoracotomy, and finally went home on foot. No further major vascular complications occurred.
Discussion
The results of our study showed that CTA using third-generation DSCT with a low tube voltage can be used to evaluate TAVI procedure planning while reducing CM and radiation dose. Usually, the volume of the contrast agent used for routine CT acquisition in TAVI procedure planning is in the range 80-120 mL. 19 ) Several studies have reported success using low tube voltage techniques for TAVI planning. Bitter, et al. 20) used 38 mL CM using a third-generation DSCT system, allowing comprehensive imaging for procedural success. Felmy, et al. 21) investigated the scope for reducing the CM dose in CTA for TAVI screening, and compared CTA using a thirdgeneration DSCT system (70 kV, 40 mL CM) with CTA using a second-generation DSCT system (100 kV, 60 mL CM). However, there was no report comparing low tube voltage and conventional tube voltage using thirdgeneration DSCT in patients for TAVI. Iodine attenuation increases at lower tube potentials due to decreased Compton scattering and greater photoelectric effect as the photon energy approaches the k-edge of iodine at 33.2 keV. 14, 15) Higashigaito, et al. 22) reported that iodine attenuation at 70 kV was higher by 51% than that at 120 kV. This effect can be used to decrease the amount of CM. Additionally, Mihl, et al. 23) reported that using CM injection protocols based on weight categories could reduce CM volume and provide diagnostically sufficient image quality in coronary CTA. In our study, the volume of CM was set according to body weight, and it was therefore possible to set the CM volume more appropriately. By using 70-kV tube voltage, we were able to reduce the CM volume to 30.9 mL (= 9.27 gI). Using this protocol, it possible to reduce the CM volume by more than 50% compared with the average volume of CM reported in the current literature. 19) In a previous report, low tube voltage imaging consistently reduced not only the CM volume but also the radiation exposure. 14) In our report, the radiation exposure dose in the 70-kV group was less than 50% that in the 120/100-kV group.
The CNR and image noise were substantially lower in the 70-kV group than in the 120/100-kV group. However, adequate sizing of the aortic annulus could be performed with high interobserver reliability in both groups, which indicates that diagnostic image quality can be obtained in the 70-kV group. Also, the CNR was consistently greater than 10 in the images of the aorto-femoral arteries, which exceeds the reported diagnostically acceptable CNR value. 13, 24) For patients undergoing TAVI, renal dysfunction is reported as one of prognostic factors in the TAVI perioperative period. 10) Previously, several studies reported the importance of reducing the CM dose and subsequently reducing the risk of CIN. 25, 26) As such, the concomitant reduction in the necessary CM dose is an advantage of the low tube voltage CTA technique for TAVI patients. To control the influence of TAVI and SAVR on renal function, we evaluated eGFR at the medium term before TAVI or SAVR. In our study, there was no difference in the change of renal function measured immediately post CTA, but renal function decreased in the 120/100-kV group within 1-3 months. In a previous report, CIN was not always a transient, benign creatininopathy, but rather a direct cause of worsening renal function. 27) Mechanisms underlying CIN include direct cytotoxic effects and viscosity for the tubules and vessels, which may cause endothelial and tubular damage during the chronic phase. 28) Our result shows that the reduction of the CM dose may be useful for the preservation of the renal function in the medium term post CTA. Limitations: Several limitations of this study need to be acknowledged. This study enrolled a small patient population, 10 patients in the 120/100-kV group and 30 patients in the 70-kV group, with a total of 40 patients. Our study might not be statistically significant owing to the small study cohort. Significant differences between groups were not observed for most patient characteristics, but the BMI of the 120/100-kV group was significantly higher. However, Wang, et al. 29) reported that patients with BMI < 23 kg/m 2 had no significant differences in image quality using 70-kV protocols of second-generation DSCT for coronary CTA compared to the 120-kV protocols. Also, Meinel, et al. 30) reported that third-generation DSCT enables one to perform coronary CTA at 70-80 kV in obese patients without compromising the CNR using the phantom-simulated obese patient. Therefore, we considered that the influence of the difference in BMI between groups was small in our study. Finally, renal function was assessed 1-3 months after CTA, but more long-term effects were not evaluated.
Conclusion
In conclusion, low tube voltage CTA using thirdgeneration DSCT is suitable to assess procedural planning for TAVI, especially in patients with a low BMI. This approach maintains image quality and reduces the required CM and radiation doses.
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